查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1317932

末期腎病市場：按治療、診斷和最終用戶分類 - 全球預測 2023-2030

End Stage Renal Disease Market by Treatment, Diagnosis, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球末期腎病市場預計到2023年將大幅成長，達到462.9億美元，複合年成長率為14.78%，預計2030年將達到驚人的1216.5億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球末期腎病市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 末期腎病的全球市場規模和預測是多少？

2.在預測期內，COVID-19 影響全球末期腎病市場的阻礙因素和影響有哪些？

3. 在預測期內，全球末期腎病市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球末期腎病市場的競爭策略是什麼？

5. 全球末期腎病市場的技術趨勢和法律規範是什麼？

6.全球末期腎病市場主要廠商的市佔率是多少？

7. 哪些型態和策略性措施被認為適合進入全球末期腎病市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 患有慢性腎臟病的人數正在迅速增加
      • 患有高血壓和糖尿病的老年人口不斷增加
      • 生活方式的改變和加工食品的消費增加
    • 抑制因素
      • 併發症的風險
    • 機會
      • 介紹新的技術增強產品
      • 增加研發活動投入並結合製造商之間的合作
    • 任務
      • 新設備核准的嚴格法規協議
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 末期腎臟病市場（依治療）

  • 透析
    • 血液透析
    • 腹膜透析
    • 穿戴式人工腎
  • 移植

第7章 末期腎病診斷市場

  • 驗血
  • 影像檢查
  • 收集腎臟樣本進行測試
  • 尿液分析

第8章 末期腎病市場：依最終用戶分類

  • 透析中心
  • 醫院和診所
  • 研究和學術機構

第9章 美洲末期腎病市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太末期腎臟病市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲末期腎臟病市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-DA46DD749C7C

The Global End Stage Renal Disease Market is forecasted to grow significantly, with a projected USD 46.29 billion in 2023 at a CAGR of 14.78% and expected to reach a staggering USD 121.65 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global End Stage Renal Disease Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global End Stage Renal Disease Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Treatment, market is studied across Dialysis and Transplantation. The Dialysis is further studied across Hemodialysis, Peritoneal Dialysis, and Wearable Artificial Kidney. The Dialysis is projected to witness significant market share during forecast period.

Based on Diagnosis, market is studied across Blood Tests, Imaging Tests, Kidney Sample Removal For Testing, and Urine Tests. The Kidney Sample Removal For Testing is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Dialysis Centres, Hospital & Clinics, and Research & Academic Institutes. The Dialysis Centres is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global End Stage Renal Disease Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global End Stage Renal Disease Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global End Stage Renal Disease Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global End Stage Renal Disease Market?

4. What is the competitive strategic window for opportunities in the Global End Stage Renal Disease Market?

5. What are the technology trends and regulatory frameworks in the Global End Stage Renal Disease Market?

6. What is the market share of the leading vendors in the Global End Stage Renal Disease Market?

7. What modes and strategic moves are considered suitable for entering the Global End Stage Renal Disease Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. End Stage Renal Disease Market, by Treatment, 2022 vs 2030
  • 4.3. End Stage Renal Disease Market, by Diagnosis, 2022 vs 2030
  • 4.4. End Stage Renal Disease Market, by End-User, 2022 vs 2030
  • 4.5. End Stage Renal Disease Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Proliferation in number of people suffering from chronic kidney disease
      • 5.1.1.2. Growing geriatric population with hypertension and diabetes
      • 5.1.1.3. Increasing lifestyle changes and consumption of processed food
    • 5.1.2. Restraints
      • 5.1.2.1. Risk of complications
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of new technologically enhanced products
      • 5.1.3.2. Increasing investment in research and development activities coupled with collaborations among manufacturers
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory protocols for the approval of new devices
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. End Stage Renal Disease Market, by Treatment

  • 6.1. Introduction
  • 6.2. Dialysis
    • 6.2.1. Hemodialysis
    • 6.2.2. Peritoneal Dialysis
    • 6.2.3. Wearable Artificial Kidney
  • 6.3. Transplantation

7. End Stage Renal Disease Market, by Diagnosis

  • 7.1. Introduction
  • 7.2. Blood Tests
  • 7.3. Imaging Tests
  • 7.4. Kidney Sample Removal For Testing
  • 7.5. Urine Tests

8. End Stage Renal Disease Market, by End-User

  • 8.1. Introduction
  • 8.2. Dialysis Centres
  • 8.3. Hospital & Clinics
  • 8.4. Research & Academic Institutes

9. Americas End Stage Renal Disease Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific End Stage Renal Disease Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa End Stage Renal Disease Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. END STAGE RENAL DISEASE MARKET RESEARCH PROCESS
  • FIGURE 2. END STAGE RENAL DISEASE MARKET SIZE, 2022 VS 2030
  • FIGURE 3. END STAGE RENAL DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
  • FIGURE 5. END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2022 VS 2030 (%)
  • FIGURE 6. END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. END STAGE RENAL DISEASE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. END STAGE RENAL DISEASE MARKET DYNAMICS
  • FIGURE 9. END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. END STAGE RENAL DISEASE MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. END STAGE RENAL DISEASE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. END STAGE RENAL DISEASE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. END STAGE RENAL DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 5. END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 6. END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. END STAGE RENAL DISEASE MARKET SIZE, BY WEARABLE ARTIFICIAL KIDNEY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 12. END STAGE RENAL DISEASE MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. END STAGE RENAL DISEASE MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. END STAGE RENAL DISEASE MARKET SIZE, BY KIDNEY SAMPLE REMOVAL FOR TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. END STAGE RENAL DISEASE MARKET SIZE, BY URINE TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS CENTRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. END STAGE RENAL DISEASE MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. END STAGE RENAL DISEASE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. END STAGE RENAL DISEASE MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 189. END STAGE RENAL DISEASE MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 190. END STAGE RENAL DISEASE MARKET LICENSE & PRICING